Status:
ENROLLING_BY_INVITATION
Emotional Release After Trigger Point Needling to Treat Myofascial Pain of the Head and Neck - Prospective Study
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Temporomandibular Disorders (TMD)
Temporomandibular Dysfunction (TMD)
Eligibility:
All Genders
18+ years
Brief Summary
Temporomandibular Dysfunction (TMD) as classified by the DC-TMD has a significant psychosocial component referred to as "Axis II". One of the methods of treatment for myofascial TMD is "needing" whic...
Detailed Description
The most common chronic pain of the orofacial region is myofascial pain related to the muscles of mastication and the neck. Which is classified according to the Diagnostic Criteria for Temporomandibu...
Eligibility Criteria
Inclusion
- The study group will include patients which consent to the study and are diagnosed with: Myalgia/Local Myalgia or Myofascial Pain or Myofascial pain with referral or Headache attributed to TMD with or without concurrent diagnosis related to the temporomandibular joint itself.
Exclusion
- Patients who are not eligible for IMS therapy will be excluded:
- PLT count under 80,000
- Active or chronic infection at site of pain
- Known allergy to amide local anesthetics
- Severe bleeding disorder such as Hemophilia
- If treated with Warfarin INR over 3
Key Trial Info
Start Date :
March 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 13 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06912438
Start Date
March 13 2025
End Date
March 13 2027
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oral Medicine Unite, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, Israel